Pfizer will provide guidance on BioPontis' product portfolio and will have options license "early-stage therapeutic opportunities"

BioPontis Alliance for Rare Disease

U.S. / Other

Other / Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!; This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Pfizer Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

Advisor / Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!; This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced